Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rectal Neoplasms 2Mouth Neoplasms 2Uterine Cervical Dysplasia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Cancer Limited Stage 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumors 1

Interventions

anlotinib 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Small Cell Lung Cancer Limited Stage × Chemoradiotherapy × Clear all
NCT04882033 2021-05-11

Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 1 Unknown
9 enrolled
Thoracic

Small Cell Lung Cancer Limited Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡